India’s V-Day: On Day 1, over 1.5 lakh beneficiaries get Covaxin/Covishield jabs, no complications so far, says health ministry

Health Tips

India’s vaccination drive against coronavirus: On Day 1 of the ‘largest inoculation campaign’ in the world, the multiple health centres across India saw enthusiastic beneficiaries getting the shots of coronavirus vaccine on Friday. In the latest briefing by the Union Health Ministry, the senior officials said that 1,65,714 registered beneficiaries received the jabs. The official also said that there was no post-vaccination hospitalisation reported so far. This essentially means that those who got the shots didn’t experience any kind of side-effects. In India, as part of the vaccination programme, the health officials are administering Covid-19 vaccines manufactured by two companies. The two vaccines – Covishield and Covaxin – are manufactured by Serum Institute of India and Bharat Biotech respectively. While Covishield is researched and developed by the University of Oxford and Astra Zeneca, the second vaccine – Covaxin- has been developed indigenously by Hyderabad- based Bharat Biotech.

Source link